Patents

Our patents represent Claret Medical’s commitment to developing unique and original products designed to help protect patients from potential strokes during Transcatheter Aortic Valve Replacement (TAVR) procedures.

The Sentinel Cerebral Protection Systemis covered by one or more of U.S. Patent Nos. 8,382,788; 9,017,364; 9,326,843; 9,345,565; 9,492,264; and 9,636,205 and European Patent Nos. 2387427 and 2480165.

Method of use covered by one or more of U.S. Patent Nos. 8,206,412; 8,372,108; 8,876,796 and 9,055,997.

Other U.S. and Foreign patents pending.